Long COVID is a chronic state that can be diagnosed when symptoms or diagnosable conditions persist for at least three months following a SARS-CoV-2 infection. ...
The pharmaceutical industry is on the cusp of a revolution. Generative AI, as highlighted in McKinsey’s 2024 report, is transforming how drugs are discovered, developed, ...
Delta4’s CEO, Kurt Herpel, and CSO, Klaus Kratochwill, were recently featured on the PharmaVentures podcast, where they discussed how Delta4 is transforming the landscape of ...
The use of multiple active ingredients in medicine is a time-honored practice, with roots stretching back to Traditional Chinese Medicine (TCM) and various formulations in ...
At Delta4, we leverage multi-omics data to identify novel drug repurposing opportunities by uncovering molecular similarities between diseases and existing drugs. This integrative approach holds ...
Developing new treatments for complex diseases presents a myriad of challenges, ranging from understanding the disease’s mechanisms to ensuring the safety and effectiveness of proposed ...
As we step into 2024, the pharmaceutical industry stands at the cusp of remarkable advancements and significant transformations. This year promises to be a pivotal ...
In the vast ecosystem of the pharmaceutical industry, drug indication expansion plays a pivotal role in maximizing the potential of existing drugs. This critical aspect ...
The world of pharmaceuticals is complex and layered. At the heart of this realm is the drug discovery pipeline, a multi-stage process that transforms scientific ...
What is Artificial Intelligence? Artificial Intelligence (AI) is a field of computer science that aims to mimic human intelligence, enabling machines to learn from experience, ...
